A seller-focused guide to selling an optometry practice, including owner objectives, buyer-accepted earnings, clinical and optical revenue, confidential buyer outreach, IOI and LOI comparison, diligence, working capital, seller proceeds, closing, and transition.
A buyer-landscape guide to eye care practice acquirers, including strategic platforms, private equity-backed groups, MSOs, physician buyers, financing, diligence, integration risk, offer structure, and seller decision-making.
A sponsor-underwriting guide to private equity in eye care, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, optical and clinical economics, cash conversion, leverage, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
A transaction-focused guide to retina practice M&A, including specialist capacity, injection and procedure mix, buy-and-bill exposure, payer and referral durability, platform demand, diligence, valuation, and seller proceeds.
A seller-focused guide to selling a dermatology practice, including owner objectives, sale readiness, buyer-accepted earnings, provider and payer durability, Mohs and pathology economics, confidential buyer outreach, IOI and LOI comparison, diligence, working capital, seller proceeds, closing, and physician transition.
A buyer-landscape guide to dermatology practice acquirers, including strategic groups, private equity-backed platforms, MSOs, physician buyers, health systems, buyer eligibility, operating fit, financing certainty, diligence, integration risk, offer structure, and seller decision-making.
A sponsor-underwriting guide to private equity in dermatology, including fragmentation, platform and add-on strategy, buyer-accepted EBITDA, Mohs and pathology economics, payer and referral durability, cash conversion, leverage, financing, integration, governance, rollover equity, downside and exit cases, diligence, offer comparison, and seller proceeds.
A buyer-underwriting guide to dermatology practice valuation, including provider mix, Mohs and pathology economics, payer and referral durability, normalized and buyer-accepted EBITDA, cash conversion, valuation methods, financing constraints, enterprise value, equity value, and seller proceeds.
A transaction-focused guide to dermatology practice M&A, connecting medical and surgical revenue quality, Mohs and pathology, referral and payer durability, platform strategy, buyer underwriting, diligence, financing, and seller outcomes.
A buyer-underwriting guide to dermatology practice valuation multiples, including accepted EBITDA, provider mix, Mohs and pathology economics, payer and referral durability, capital intensity, acquirer demand, financing constraints, diligence sensitivity, and seller proceeds.